Cell & Gene Therapy Products Europe

Cell and Gene Therapy Products Europe: Manufacturing, Quality and Regulatory Considerations 

The Cell and Gene Therapy Products (CGTP) Europe Symposium: Manufacturing, Quality and Regulatory Considerations enables the exchange of scientific knowledge, innovations, and strategies between industry, regulators, and academia. These discussions can form the basis from which to evolve both industry and regulatory practices in the development of these diverse and innovative products. 

The Cell and Gene Therapy Products (CGTP) Europe Symposium will debut in 2025 as an extension of the Cell and Gene Therapy Products Symposium. This Symposium is designed to provide an opportunity in Europe for the discussion of specific European issues while maintaining a global outlook. The 2025 Symposium will explore how to continue adapting concepts derived from other biologics specifically to CGTP and how to establish novel approaches where they are needed.

For more information about CGTP Europe, contact Randi Jacobs.